D.C. Circuit Upholds FDA’s Summary Judgment In Generic Drug Approval Case
WASHINGTON, D.C. — Novartis Pharmaceuticals Corp.’s arguments on appeal, disputing a district court judge’s denial of its motion for summary judgment in a case contesting the U.S. Food and Drug Administration’s...To view the full article, register now.
Already a subscriber? Click here to view full article